Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria

Mechanisms of Ageing and Development

Volumn 112, Issue 1, 1999, Pages 27-42

  Swegert, Cyril V ^a   Dave, Kunjan R ^a   Katyare, Surendra S ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Aluminium; Alzheimer's disease; ATPase; Membrane fluidity; Mitochondria; Oxidative phosphorylation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ALUMINUM; ASCORBIC ACID; GLUTAMIC ACID; SUCCINIC ACID;

AEROBIC METABOLISM; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENERGY METABOLISM; HEART; LIVER; MEMBRANE FLUIDITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SENILITY;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; AGING; ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; BODY TEMPERATURE; BRAIN; CHLORIDES; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUTAMIC ACID; MALE; MEMBRANE FLUIDITY; MITOCHONDRIA, HEART; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; RATS;

ANIMALIA;

EID: 0032701899     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(99)00051-2     Document Type: Article

References (43)

1. Ashall F., Goate A.M. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biol.Sci. 19:1994;42-46.
2. Bangur C.S., Howland J.L., Katyare S.S. Thyroid hormone treatment alters phospholipid composition and membrane fluidity of the rat brain mitochondria. Biochem. J. 305:1995;29-32.
3. Bartlett G. R. Phosphorous assay in column chromatography. J. Biol. Chem. 234:1954;466-468.
4. Bassett J., Denney R.C., Jeffery G.H., Mendham J. Vogel's Text Book of Quantitative Inorganic Analysis. 4th edition:1978;729-730 Longman, England.
5. Berlyne G.M., Yagil R., Ari J.B., Weinberger G., Knopf E., Denovitch G.M. Aluminium toxicity in rats. Lancet. i:1972;564-567.
6. Bilkei G.A. Neurotoxicity effect of enteral aluminium. Food. Chem. Toxicol. 31:1993;357-361.
7. Bindoff L.A., Birch-Machin M.A., Cartlidge N.E.F., Parker W.D., Turnbull D.M. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104:1991;203-208.
8. Crapper D.R., Krishnan S.S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 99:1976;67-80.
9. Crowther R.A. Steps towards a mouse model of Alzheimer's disease. BioEssays. 17:1995;593-595.
10. Dave B.N., Billimoria F.R., Katyare S.S. Altered kinetic properties of rat heart mitochondrial enzymes following experimental thyrotoxocosis. J. Biosci. 14:1989;341-349.
11. Davis W.M. Is aluminium an etiologic contributor to alcoholic amnesia and dementia? Med. Hypothesis. 41:1993;341-343.
12. Deloncle R., Guillard O. Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication. Neurochem. Res. 15:1990;1239-1245.
13. Ferreira J., Gil L. Nutritional effects on mitochondrial bioenergetics alterations in oxidative phosphorylation by rat liver mitochondria. Biochem. J. 218:1984;61-67.
14. Fiske C. H., Subba Row Y. Colorimetric determination of phosphorous. J. Biol. Chem. 66:1925;375-400.
15. Folch J., Less M., Sloane-Stanley G.H. A simple method for isolation and purification of total phospholipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
16. Halverson K., Fraser P.E., Kirschner D.A., Lansbury P.T. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments. Biochemistry. 29:1990;2639-2644.
17. Hutchin T., Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 92:1995;6892-6895.
18. Jani M.S., Telang S.D., Katyare S.S. Effect of corticosterone treatment on energy metabolism in rat liver mitochondria. J. Steroid Biochem. Molec. Biol. 38:1991;587-591.
19. Katyare S.S., Bangur C.S., Howland J.L. Is respiratory activity in the brain mitochondria responsive to thyroid hormone action?: a critical re-evaluation. Biochem. J. 302:1994;857-860.
20. Katyare S.S., Joshi M.V., Fatterpaker P., Sreenivasan A. Effect of thyroid deficiency on oxidative phosphorylation in rat liver, kidney and brain mitochondria. Arch. Biochem. Biophys. 182:1977;155-163.
21. Kish S.J., Chang L.J., Wilson J.M., Distenfuna L.M., Noberga N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 590:1992;776-779.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Nakagawa-Hattori Y., Yoshino H., Konda T., Mizuno T., Horai S. Is Parkinson's disease a mitochondrial disorder? J. Neurol. Sci. 107:1992;29-33.
24. Mackler B., Haynes B., Inamdar A.R., Pedegana L.R., Hall J.G., Cohen N.N. Oxidative energy deficiency II. Human Achondroplacia. Arch. Biochem. Biophys. 159:1973;885-888.
25. McDermott J.R., Smith A.I., Khalid I., Wisniewiski H.M. Brain aluminium in ageing and Alzheimer's disease. Neurology. 29:1979;809-814.
26. Mehta J.R., Braund K.G., Hegreberg G.A., Thukral V. Lipid fluidity and composition of the erythrocyte membrane from healthy dogs and Labrador retrievers with hereditary muscular dystrophy. Neurochem. Res. 16:1991;129-135.
27. Pandya, J.D., 1997. Aluminium induced Alzheimer-like condition and membrane function alterations in the rat brain. MSc. Dissertation, MS University of Baroda, India.
28. Parmar D.V., Ahmed G., Khandkar M.A., Katyare S.S. Mitochondrial ATPase: a target for paracetamol-induced hepatotoxicity. Eur. J. Pharmacol. 293:1995;225-229.
29. Potter V.R. The homogenate technique. Umbreit W.W., Burris R.H., Stauffer J.H. Manometric and Biochemical Techniques. 5th edition:1972;177-195 Burgess, Minneapolis, Minnesota.
30. Richter C. Do mitochondrial DNA fragments promote cancer and ageing? FEBS Lett. 241:1988;1-5.
31. Roth G.S., Joseph J.A., Mason R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and ageing. Trends Neurol. Sci. 18:1995;203-206.
32. Satav J.G., Katyare S.S. Effect of experimental thyrotoxicosis on oxidative phosphorylation in rat liver, kidney and brain mitochondria. Molec. Cell Endocrinol. 28:1982;173-189.
33. Schnabel J. Alzheimer's disease: arthritis of the brain? New Sci. 138:1993;22-26.
34. Schapira A.V.H., Cooper M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:1990;823-827.
35. Skipski V.P., Barclay M., Barclay R.K., Fetzer V.A., Good J. J., Archibald F.M. Lipid composition of human serum lipoprotein. Biochem. J. 104:1967;340-361.
36. Smith M.A., Sayer L.M., Monnier V.M., Perry G. Radical ageing in Alzheimer's disease. Trends Neurol. Sci. 18:1995;172-176.
37. Swegert, C.V., 1996. Effect of aluminium induced Alzheimer-like condition in rats on mitochondrial oxidative energy metabolism. MSc. Dissertation, MS University of Baroda, India.
38. Syal, A., 1996. Effect of aluminium-induced Alzheimer like condition on tissue cholinesterases in the rat. MSc. Dissertation, MS University of Baroda, India.
39. Tanaka M., Nishikimi M., Suzuki H., Ozawa T., Okino E., Takahashi H. Multiple cytochrome deficiency and deteriorate mitochondrial polypeptide composition in fatal infantile mitochondrial myopathy and dysfunction. Biochem. Biophys. Res. Commun. 137:1986;911-916.
40. Wallace D.C., Sing G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M.S., Elsac II L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 242:1988;1427-1430.
41. Wurtman R.J. Alzheimer's disease. Sci. Am. 252:1985;48-56.
42. Zlatkis A., Zak B., Boyle J.A. A new method for the determination of serum cholesterol. J. Lab. Clin. Med. 41:1953;486-492.
43. Zhong X., Shoffner J.M., Voljavec A.S., Wallace D.C. Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim. Biophys. Acta. 1019:1990;1-10.